Biogen Inc (BIIB)
202.49
+0.50
(+0.25%)
USD |
NASDAQ |
Apr 25, 16:00
198.46
-4.03
(-1.99%)
After-Hours: 20:00
Biogen Profit Margin (Quarterly): 10.46% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.46% |
| September 30, 2023 | -2.69% |
| June 30, 2023 | 24.09% |
| March 31, 2023 | 15.75% |
| December 31, 2022 | 21.64% |
| September 30, 2022 | 45.23% |
| June 30, 2022 | 40.86% |
| March 31, 2022 | 12.00% |
| December 31, 2021 | 13.47% |
| September 30, 2021 | 11.85% |
| June 30, 2021 | 16.16% |
| March 31, 2021 | 15.23% |
| December 31, 2020 | 12.55% |
| September 30, 2020 | 20.78% |
| June 30, 2020 | 41.89% |
| March 31, 2020 | 39.59% |
| December 31, 2019 | 39.22% |
| September 30, 2019 | 42.94% |
| June 30, 2019 | 41.31% |
| March 31, 2019 | 40.37% |
| December 31, 2018 | 26.85% |
| September 30, 2018 | 42.00% |
| June 30, 2018 | 25.82% |
| March 31, 2018 | 37.46% |
| December 31, 2017 | -8.99% |
| Date | Value |
|---|---|
| September 30, 2017 | 39.84% |
| June 30, 2017 | 28.03% |
| March 31, 2017 | 26.60% |
| December 31, 2016 | 22.60% |
| September 30, 2016 | 34.94% |
| June 30, 2016 | 36.27% |
| March 31, 2016 | 35.61% |
| December 31, 2015 | 29.29% |
| September 30, 2015 | 34.76% |
| June 30, 2015 | 35.78% |
| March 31, 2015 | 32.19% |
| December 31, 2014 | 33.46% |
| September 30, 2014 | 34.12% |
| June 30, 2014 | 29.51% |
| March 31, 2014 | 22.54% |
| December 31, 2013 | 23.26% |
| September 30, 2013 | 26.68% |
| June 30, 2013 | 28.47% |
| March 31, 2013 | 30.16% |
| December 31, 2012 | 20.60% |
| September 30, 2012 | 28.75% |
| June 30, 2012 | 27.22% |
| March 31, 2012 | 23.43% |
| December 31, 2011 | 14.53% |
| September 30, 2011 | 33.72% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.69%
Minimum
Sep 2023
45.23%
Maximum
Sep 2022
24.33%
Average
20.78%
Median
Sep 2020
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 23.41% |
| Bristol-Myers Squibb Co | 15.35% |
| Gilead Sciences Inc | 20.09% |
| AbbVie Inc | 5.75% |
| Regeneron Pharmaceuticals Inc | 33.77% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.19% |
| Return on Assets | 4.49% |
| Return on Invested Capital | 5.58% |
| Gross Profit Margin (Quarterly) | 74.09% |
| Operating Margin (Quarterly) | 19.18% |
| Return on Net Operating Assets | 6.45% |